paulynn - stock.adobe.com
By Steve Brownett Gale of Lifestyle Packaging
“The results of a study recently revealed 92 percent of CBD products contain less than advertised, with just eight percent having concentrations within 10 percent of the advertised strength.
“This is extremely worrying, especially as it’s not the first time the issue has been highlighted.
“CBD products are bought for many reasons, such as to provide pain relief and help you relax, without any mind-altering effects. In the UK, products are required to contain less than 0.2 percent THC and the daily recommended dose is 1,500mg a day, however, this can fluctuate depending on the product and its purpose.
“If customers are recommended two drops a day, for example, a drop of a mislabelled product won't have the desired effect and could see them self-administering more. This can lead to unpleasant side effects such as diarrhoea, vomiting and drowsiness and can interact with other medications.
“Therefore, providing inaccurate information on packaging is not only misleading, it can impact health and will likely result in a decrease in customer and supplier satisfaction and loyalty.
“Suppliers want to ensure the product they are stocking is trustworthy and profitable, while customers want to buy products that have the desired effects.
“CBD product labelling should be in strict accordance with the United Kingdom Food Labelling Regulations 1996, which states products are sold with legally correct and accurate descriptions for consumers’ best interests.
“Therefore, when packaging products, brands have a responsibility to not only test and ensure the potency of the product is correct, but that they are labelled correctly.”